Concepedia

Shaw-Cheng Liu

SL

Statistics

Publications

10

Citations

823

H-Index

10

Active since

2009

Affiliations

National University Cancer Institute, Singapore(Current)

National University of Singapore

Agency for Science, Technology and Research

National University Health System

Genome Institute of Singapore

Shaw-Cheng Liu is an author at National University Cancer Institute, Singapore specializing in molecular oncology, medicine, and oncology.

Publications per year

2009–2016

10

Publications

10

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML

Jianbiao Zhou, Chonglei Bi, Lip-Lee Cheong et al. · Blood · 2011 · 212 citations · Full text

, , +15

EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity

Junli Yan, Siok‐Bian Ng, Jim Liang-Seah Tay et al. · Blood · 2013 · 165 citations

, , +16

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara et al. · Blood · 2009 · 162 citations · Full text

, , +9

ITIH3 Is a Potential Biomarker for Early Detection of Gastric Cancer

Poh Kuan Chong, Huiyin Lee, Jianbiao Zhou et al. · Journal of Proteome Research · 2010 · 83 citations

, , +15

Reduced plasma APOA1 level is associated with Gastric Tumor Growth in MKN45 mouse xenograft model

Poh‐Kuan Chong, Huiyin Lee, Jianbiao Zhou et al. · Journal of Proteomics · 2010 · 57 citations

, , +8

1–5 of 10